A drug originally designed to target cancer has been found to restore memory and reverse cognitive problems in mice with Alzheimer's disease-like symptoms and could offer a path forward to a treatment for humans someday, a new study found. Yale University researchers found that the previously approved drug, saracatinib, targeted beta amyloid deposits and reduced their toxic effect on surrounding brain cells.
http://ift.tt/1IjIQ4K
http://ift.tt/1IjIQ4K
No comments:
Post a Comment